The observation that cyclin B1 protein and mRNAs are down-regulated in terminally dierentiated (TD) C2C12 cells, suggested us to investigate the transcriptional regulation of the cyclin B1 gene in these cells. Transfections of cyclin B1 promoter constructs indicate that two CCAAT boxes support cyclin B1 promoter activity in proliferating cells. EMSAs demonstrate that both CCAAT boxes are recognized by the trimeric NF-Y complex in proliferating but not in TD cells. Transfecting a dominant-negative mutant of NF-YA we provide evidence that NF-Y is required for maximal promoter activity. Addition of recombinant NF-YA to TD C2C12 nuclear extracts restores binding activity in vitro, thus indicating that the loss of NF-YA in TD cells is responsible for the lack of the NF-Y binding to the CCAAT boxes. Consistent with this, we found that the NF-YA protein is absent in TD C2C12 cells. In conclusion, our data demonstrate that NF-Y is required for cyclin B1 promoter activity. We also demonstrate that cyclin B1 expression is regulated at the transcriptional level in TD C2C12 cells and that the switch-o of cyclin B1 promoter activity in dierentiated cells depends upon the loss of a functional NF-Y complex. In particular the loss of NF-YA protein is most likely responsible for its inactivation.
Introduction
In mammalian cells the G2/M transition is controlled by a speci®c set of cell cycle genes: the mitotic cyclins (A, B1, B2), the mitotic kinase cdk1 alias cdc2 p34 and the cdc25C phosphatase (Draetta et al., 1987; Murray et al., 1989; Pines and Hunter, 1990) . The expression of these genes is tightly controlled, during the cell cycle, both at transcriptional (Dalton, 1992; Hwang et al., 1995; Henglein et al., 1994; Katula et al., 1997; Lucibello et al., 1995; Piaggio et al., 1995; Pines and Hunter, 1990; Zwicher et al., 1995) and translational (Brandeis and Hunt, 1996; Draetta et al., 1989; Millar et al., 1991; Murray et al., 1989; Strausfeld et al., 1991) levels and impairment in their regulated expression is thought to contribute to the malignant phenotype (Buckley et al., 1993; Keyomarsi and Pardee, 1993) .
It has been reported that transcriptional regulation of cyclin B1 gene is, at least in part, responsible for the loss of expression in quiescent cells (Hwang et al., 1995; Piaggio et al., 1995) . We have previously reported that a palindromic E-box sequence, CACGTG, located at position 7124/7119 in the promoter region, plays a crucial role as a quiescence responsive element (Farina et al., 1996) . Interestingly, it has been reported that the mRNA of cyclin B1 is also down-regulated in myoblast upon induction of terminal dierentiation (Millar et al., 1991) . We asked whether the same molecular mechanisms previously observed in quiescent cells, could be responsible for the down-regulation of the cyclin B1 expression in terminally dierentiated muscle cells. To answer this question we used skeletal muscle C2C12 cells. Proliferating precursors, or myoblast, can be induced to dierentiate by growth factor withdrawal. Growth factor-starved myoblasts irreversibly exit from the cell cycle and express muscle-speci®c genes, while downregulating a number of cell cycle regulators among which are mitotic cyclins and the mitotic kinase cdk1 (Ohkubo et al., 1994; Tiainen et al., 1996) . The resulting terminally dierentiated (TD) myocytes eventually fuse with one another to generate multinucleated cells termed myotubes (Okazaki and Holter, 1966) .
The results presented here indicate that the downregulation of the cyclin B1 expression in terminally dierentiated muscle cells is mediated by molecular mechanisms dierent from those previously observed in quiescent cells. Two CCAAT boxes located close to the Cap site, but not the E-box sequence located at position 7124/7119 in the promoter region, mediated the down-regulation of cyclin B1 promoter activity in terminally dierentiated muscle cells. These CCAAT boxes are essential for the transcriptional regulation of cyclin B1 gene and their inactivation is responsible for the loss of promoter activity. CCAAT boxes are bound with high anity and speci®city by an ubiquitous trimeric complex, NF-Y. This complex is composed of three highly conserved subunits NF-YA, NF-YB, and NF-YC (Bellorini et al., 1997; Hooft van Huijsduijnen et al., 1990) , all required for DNA binding (Sinha et al., 1995) . In the MHC class II Ea promoter, which has no functional TATA box, NF-Y appears to play an important role in correctly positioning the start site together with an initiator element (Dorn et al., 1987; Mantovani et al., 1993) . Functional analysis has shown that NF-Y can be important in transcription re-initiation, suggesting a role in basal transcription (Mantovani et al., 1992) . In the promoters of the genes encoding the mitotic cyclin A as well as the CDK1 kinase and the CDC25C phosphatase and other cell cycle regulated genes, several CCAAT elements are present, that have been reported to be recognized by the NF-Y complex (Zwicher et al., 1995) .
In the present paper we report that: (i) the two CCAAT boxes located close to the Cap site support cyclin B1 basal promoter activity; (ii) the loss of a functional NF-Y complex is responsible for the downregulation of the promoter activity; (iii) NF-YA protein is the limiting factor for NF-Y binding activity in TD cells; (iv) the lack of NFY-A protein in TD cells is, at least in part, responsible for the down-regulation of cyclin B1 promoter activity in these cells.
Results

Down-regulation of cyclin B1 expression in TD C2C12 cells occurs at transcriptional level
In dierent cell types, cyclin B1 expression seems to be restricted to the proliferating state, being downregulated in growth arrested or dierentiated cells (Doerner et al., 1996; Fromm and Overbeek, 1996; Hanley-Hyde et al., 1992; Zhao et al., 1995) . It has been reported that the cyclin B1 mRNA is downregulated in C2C12 myoblasts upon induction of terminal dierentiation (Ohkubo et al., 1994) . We asked whether cyclin B1 protein expression is also down-regulated. To answer this question, the levels of both cyclin B1 protein and mRNAs were evaluated in proliferating and TD C2C12 cells. Northern blot hybridization experiments (Figure 1a) , and Western blot assays (Figure 1b) , show that the amount of cyclin B1 transcripts and protein, dramatically decreases in post-mitotic myotubes.
To investigate whether down-regulation of cyclin B1 mRNA occurs at the transcriptional level, C2C12 cells were stably cotransfected with CAT reporter constructs driven by two dierent cyclin B1 promoter fragments (p332B1CAT and p240B1CAT) (Piaggio et al., 1995) . Upstream to the CAT reporter gene, the plasmids carry the wild-type cyclin B1 promoter fragment from 7154 to +182 bp (p332B1CAT), or a 5' deletion (757 to +182 bp) of this promoter (p240B1CAT). We have previously reported that both promoter fragments drive comparable transcription in proliferating NIH3T3 cells (Piaggio et al., 1995) . Similar results were obtained in proliferating C2C12 cells (data not shown). As a control, a C2C12 RSVCAT transfected polyclonal population (a kind gift from Silvia Soddu) was employed. Figure 2 shows that both cyclin B1 promoter constructs are capable of driving transcription in C2C12 proliferating cells. In contrast, no transcriptional activity is detected in TD cells with both constructs (Figure 2 ), whereas the transcriptional activity of the viral RSV promoter is not downregulated by terminal dierentiation (data not shown).
Taken together these results demonstrate that cyclin B1 protein, mRNA, and promoter activity are downregulated in TD C2C12 cells, indicating that the expression of cyclin B1 gene in these conditions is regulated, at least in part, at transcriptional level. Moreover, the ®nding that the shorter construct (p240B1CAT) becomes inactive in TD cells indicates that the region from 757 bp to +182 bp upstream of the start site contains elements required for the downregulation of cyclin B1 promoter activity in TD cells. Figure 1 Cyclin B1 expression is down-regulated in TD C2C12. (a) Northern blot analysis was performed on total RNA extracted from proliferating, P, and TD C2C12 cells. 25 mg of total RNAs were size-fractionated on a 1% agarose gel, blotted on a nylon membrane, hybridized with 32 P-labelled cyclin B1 probe and assessed by auto-radiography. To normalize RNA loading, the membrane was re-hybridized with the 32 P-labelled cDNA of the house-keeping gene GAPDH. (b) Western blot analysis was performed on total cell lysates from proliferating, P, and TD C2C12 cells. The extracts were probed with a monoclonal antibody anti-cyclin B1. To normalize protein loading, the ®lter was stained with a rabbit polyclonal antiserum raised against CREB protein
The CCAAT boxes in the cyclin B1 promoter play a functional role on its basal transcriptional activity
Computer assisted analysis of the sequence from nucleotides 757 to +182 reveals the presence of two putative CCAAT boxes located at position 714 to 717 and +16 to +20 of the cyclin B1 promoter. In order to investigate the functional contribution of these elements to the promoter activity, mutations were introduced in the wild-type promoter (CCAAT to CTCGA). We generated three CAT reporter constructs carrying mutations in the upstream (pmtupCCAAT), downstream (pmtdownCCAAT) or in both (pmtup/ downCCAAT) boxes in the context of the shorter construct p240B1CAT. Mutated and wild-type constructs were transiently transfected in proliferating C2C12 cells. The CAT activity of p240B1CAT construct was made 100%, and the relative activity of the CCAAT mutated plasmids was calculated. As shown in Figure 3 , the single mutation of either CCAAT box does not signi®cantly aect promoter activity; while the mutations of both boxes reduce by 80% the promoter activity, indicating that the two CCAAT boxes are key sequences for the cyclin B1 promoter activity. Interestingly, these data also indicate that in these experiments each CCAAT box on its own is sucient to support basal promoter activity.
NF-Y protein complex binds the CCAAT boxes in proliferating but not in TD C2C12 cells By EMSAs we veri®ed the presence of nuclear factors binding to the CCAAT boxes in proliferating and TD cells. Electromobility shift assays reveal one protein complex binding to two radiolabelled probes, spanning nt 726 to +1 and 73 to +29 respectively in the cyclin B1 promoter (B1upCCAAT and B1down-CCAAT) (Figure 4a ). The binding activity of the complex present in nuclear extracts from proliferating cells (lanes 2 and 12) indicates that the CCAATbinding complex is highly abundant in proliferating cells. By contrast, the complex is almost undetectable in the nuclear extracts prepared from terminally dierentiated cells (lanes 7 and 17). Competition assays were then designed with both cyclin B1-derived probes to asses the binding speci®city of the complex to the CCAAT boxes. As shown in Figure 4a , the complex is speci®cally inhibited by a 200-fold molar excess of unlabelled probes (lanes 3 and 13), but not by a 1000-fold molar excess of a similar oligonucleotides containing a mutated CCAAT box (lanes 5 and 15), or by an unrelated probe containing an E-box sequence (lanes 6 and 16). Although in these experiments a non reproducible faster migrating complex is also barely detectable with both probes (lanes 2 and 12), it is Figure 2 The down-regulation of cyclin B1 expression in TD C2C12 cells occurs at transcriptional level. Cyclin B1 promoter CAT-reporter constructs p332B1CAT and p240B1CAT (Piaggio et al., 1995) , were stably transfected by calcium-phosphate in C2C12 cells. The obtained poly-clonal cell lines were analysed for the CAT activity. CAT assay was performed as described (Desvernie et al., 1991) . The values in TD cells are expressed, on Y axis, as percentages of the CAT activity obtained from proliferating cells (100%). Results represent one typical experiment. A schematic representation of the two used reporter constructs is represented Figure 3 The CCAAT boxes, present in the cyclin B1 promoter, play a functional role on its basal transcriptional activity. Cyclin B1 promoter-CAT reporter constructs (10 mg), p240B1CAT, pmtupCCAAT, pmtdownCCAAT or pmtup/downCCAAT were contransfected by the calcium-phosphate method into proliferating C2C12 cells along with the CMVb-gal reporter construct (1 mg). CAT assays were performed as described (Desvernie et al., 1991) . The CAT activity of p240B1CAT was made 100%, and the relative activities of the mutated constructs are indicated. Results represent the mean of three independent experiments each performed in duplicate. A schematic representation of the used reported constructs is represented inhibited by all tested competitors indicating that it does not re¯ect speci®c binding. This ®nding demonstrates that one protein complex speci®cally binds both the B1upCCAAT and B1downCCAAT probes in vitro. The observation that CREB-binding activity does not change in dierent cell populations (proliferating versus terminally dierentiated, Figure 4b ) con®rms that the loss of CCAAT binding complex in TD cells can not be attributed to trivial technical problems.
It has been reported that both CTF/NF1 (Zorbas et al., 1992) and C/EBP (Osada et al., 1996) , bind CCAAT-related sequences, while NF-Y binds a CCAAT consensus sequence that ®ts very well with the statistically derived one (Bucher, 1990) . In order to gain information about the identity of the proteins that bind the CCAAT boxes of the cyclin B1 promoter, we performed competition experiments using both B1upCCAAT and B1downCCAAT radiolabelled probes and cold competitor oligonucleotides containing the speci®c cognate sequences for the NF1/CTF family of proteins, for C/EBP, and for CBF/NF-Y. Only the oligonucleotide containing the CBF/NF-Y recognition sequence is able to compete out the cyclin B1 CCAAT-binding complexes (data not shown), indicating that NF-Y complexes bind the CCAAT boxes of the cyclin B1 promoter. Direct evidence of the NF-Y binding was obtained through the use of speci®c antibodies against either NF-YA or NF-YB in the binding reactions with both radio-labelled probes. C2C12 nuclear extracts were pre-incubated with antibodies against the NF-YA or NF-YB subunits but not against NF-YC protein because this was still unavailable. As shown in Figure 4c NF-YA antibody retards the migration of the assembled complex with both probes (lanes 3 and 7); the NF-YB antibody, but not a pre-immune serum (lanes 2 and 6), retards, as well as interferes with, the migration of the complex (lanes 4 and 8). Altogether, these results provide evidence that, at least in vitro, NF-Y recognizes the two cyclin B1 CCAAT boxes.
Figure 4 (a) Protein complexes bind the two CCAAT boxes of the cyclin B1 promoter only in proliferating cells. Gel mobility retardation assays were performed with two double-stranded, 32 Pmlabelled oligonucleotides, spanning position 726 to +1 (B1upCCAAT) and 73 to +29 (B1downCCAAT) containing the two CCAAT boxes of the cyclin B1 promoter. On both probes, addition of nuclear extracts from proliferating (C2C12 PNE, lanes 2 and 12), but not from TD (C2C12 TDNE, lanes 7 and 17) C2C12 cells resulted in a retarded band indicated by the arrows. Lanes 1 and 11 represent the B1downCCAAT and B1upCCAAT free probes respectively. The formation of the complex is speci®cally inhibited by a 200-fold molar excess of unlabelled probe (lanes 3 and 13) but not by a 1000-fold molar excess of oligonucleotides containing a mutated CCAAT box in which this sequence is changed into CTCGA (lanes 5 and 15) or a 1000-fold molar excess of an unrelated probe (lanes 6 and 16). (b) Gel mobility retardation assays were performed with a doublestranded, 32 P-labelled oligonucleotide, containing the CRE element of the somatostatin promoter. Lane 1 represents the CRE free probe, lanes 2 and 3 represent the retarded bands obtained with addition of nuclear extracts from proliferating and TD C2C12 cells, respectively. (c) NF-Y complex binds the two CCAAT boxes of the cyclin B1 promoter. Gel mobility retardation assays were performed with 32 P-labelled probes as in (a). Nuclear extracts from proliferating cells (P NE), before assay with probes, were preincubated with a pre-immune serum (lanes 2, 6) a monoclonal antibody anti-NF-YA (mAb YA7) (Mantovani et al., 1992) (lanes 3, 7) and a polyclonal antiserum raised aganst the recombinant NF-YB protein (pRaYB) (Mantovani et al., 1992) (lanes 4, 8) . Both antibodies super-shift the complex. The supershifted bands are indicated by the arrows NF-Y plays an essential role in the cyclin B1 transcription in vivo To evaluate the functional signi®cance of NF-Y complex on the cyclin B1 promoter activity in vivo we over-expressed NF-YA mutant cDNA in proliferating C2C12 cells. The cells were cotransfected with the cyclin B1 promoter and dierent amounts of NF-YA mutant expression vector. It is known that the NF-YA mutant inhibits NF-Y dependent transcription by sequestering the NF-YB and NF-YC subunits in defective complexes, which are unable to bind the DNA, thus functioning as a dominant negative protein (Mantovani, 1998) . In all experiments, the basal activity (100%) was assessed by co-transfecting the empty vector along with the CAT construct p240B1CAT (lane 1). Repeated experiments were performed and similar results were observed; nevertheless, minimal variations were observed in dierent cell lysates. Analysis of CAT activity reported in Figure 5 demonstrates that (a) the over-expression of mutant NF-YA protein completely abrogate cyclin B1 promoter activity as expected for a dominant negative protein, and (b) its eect is dose-dependent. As shown in Figure 5 , 2.5 mg of NF-YA mutant-expressing plasmid decreases by 70% the transcriptional activity of the p240B1CAT construct whereas the higher dose of plasmid (5 mg) decreases transcription by 98%. The speci®city of the eects generated by mutant NF-YA protein on cyclin B1 promoter activity was also con®rmed by co-transfecting a reporter gene driven by SV40 promoter (pSV2CAT). The over-expression of NF-YA dominant negative protein does not significantly aect the SV40 promoter activity ( Figure 5 ).
Taken together these results demonstrate that the transfection of a dominant negative analogue of NF-YA speci®cally inhibits cyclin B1 promoter activity in a dose-dependent manner, thus giving direct evidence that a functional NF-Y complex is required for maximal promoter activity.
The expression of NF-Y genes is down-regulated in TD C2C12 cells
Next we evaluated whether the lack of binding of NF-Y complexes to the CCAAT boxes on the cyclin B1 promoter in TD C2C12 cells could be attributed to a lack of the expression of the three NF-Y subunits. Northern blot analysis of total RNAs prepared from proliferating and TD C2C12 cells was performed. Figure 6a shows that the levels of the three NF-Y subunits transcripts decrease in TD C2C12 cells. As assessed by densitometric analysis, the dierentiationassociated decrease in mRNA levels was of 59 and 56% for NF-YB and NF-YC respectively and 70% for NF-YA mRNA. To assess whether the expression of the NF-Y proteins parallels that of mRNAs Western blot analysis was performed. Figure 6b shows that the NF-YA protein is absent in TD cells, whereas the NF-YB protein is signi®cantly reduced. The reduction in the level of expression of NF-YB protein in TD cells parallels the down-regulation of its mRNA, suggesting a transcriptional regulation of this protein during the dierentiation process. By contrast, the lack of NF-YA protein expression in TD C2C12 cells does not match with the presence of detectable levels of NFY-A mRNA. This ®nding strongly suggests that the expression of NF-YA protein during dierentiation is regulated both at transcriptional and translational levels. Furthermore, the signi®cant reduction of NF-YA protein in TD C2C12 cells has been interpreted as the event responsible for the lack of NF-Y binding to the CCAAT boxes of the cyclin B1 promoter and the inhibition of the promoter activity in post-mitotic cells.
NF-YA protein is the limiting factor for the binding of NF-Y complex in TD C2C12 cells
To assess whether loss of the binding of NF-Y complex to the CCAAT boxes of cyclin B1 promoter in TD C2C12 cells could be attributed to loss of NF-YA protein we performed electromobility shift assays adding decreasing amounts of recombinant puri®ed NF-YA protein to the nuclear extracts from these cells. As shown in Figure 7 , the addition of 3 ng of puri®ed NF-YA protein to TD nuclear extract is sucient to fully restore in vitro binding activity of the NF-Y complex to both the B1upCCAAT (lane 6) and B1downCCAAT (data not shown) probes in vitro. The addition of puri®ed NF-YA protein to nuclear extracts from proliferating cells does not substantially modify the complex mobility, but it induces a signi®cant increase in the complex formation (lane 7 and data not shown). The addition of recombinant puri®ed NF-YB/NF-YC dimer to the nuclear extracts obtained from TD C2C12 cells does not restore the binding activity of the NF-Y complex to both B1upCCAAT (lane 11) and B1downCCAAT (data not shown) nor increase the complex formation in nuclear extracts from proliferating cells (lane 9 and data not shown). The observation that the addition of recombinant puri®ed NF-YA/NF-YB/NF-YC trimer to the nuclear extracts obtained from proliferating and TD C2C12 cells fully restores binding activity of the NF-Y complex to both B1upCCAAT (lanes 12 and 13) and B1downCCAAT (data not shown) demonstrates that the recombinant NF-YB/NF-YC dimer is active, and the fact that it does not restore the binding activity of the NF-Y complex in TD cells can not be attributed to trivial technical problems.
Altogether these results clearly demonstrate that the NF-YA protein is a limiting factor for binding to the CCAAT box in post-mitotic cells at least in vitro, and suggest a functional role for the loss of NF-YA protein in the regulation of cyclin B1 promoter activity in TD cells. Moreover, the observation that the amount of NF-YA in proliferating cells determines the levels of DNA binding activity of the NF-Y complex (compare lane 2 with lane 7) is in good agreement with the ®nding that NF-YB and C are expressed at higher levels than NF-YA in proliferating cells (RM, unpublished observation).
Overexpression of NF-YA in vivo is switched o in TD C2C12 cells
To investigate whether loss of NF-YA protein in TD C2C12 is responsible for the down-regulation of cyclin B1 promoter activity in vivo, we transient transfected NF-YA cDNA along with cyclin B1 promoter in C2C12 proliferating cells and, after serum withdrawal, we evaluated CAT activity in TD cells. Despite several attempts we were not able to restore cyclin B1 promoter activity in TD C2C12. Western blot analysis was performed to assess the level of NF-YA expression achieved after transfection of exogenous gene. Nuclear extracts from NF-YA transfected myoblasts and myotubes and, as control, from NF-YB transfected cells were prepared and the results are reported in Figure 8 . Densitometric analysis demonstrate that in Figure 6 The expression of NF-Y genes is down-regulated in TD C2C12 cells. (a) Northern blot analysis was performed on total RNA extracted from proliferating, P, and TD C2C12 cells. 10 mg of total RNAs were size-fractionated on a 1% agarose gel, blotted on a nylon membrane, hybridized with 32 P-labelled cyclin B1 probe and assessed by auto-radiography. To normalize RNA loading, the membrane was re-hybridized with the 32 P-labelled cDNA of the house-keeping gene GAPDH. The percentage of decrease amount of each mRNA has been evaluated by densitometric analysis performed as in Figure 5a . The sizes of the transcripts are indicated. (b) Western blot analysis was performed on total cell lysates from P and TD C2C12 cells. The extracts were probed with two polyclonal antiserum raised against a C-terminal peptide of NF-YA (pRaYA/C) (Mantovani et al., 1992) or against the recombinant NF-YB protein (pRaYB) (Mantovani et al., 1992) respectively. To normalize protein loading, the ®lter was stained with a rabbit polyclonal antiserum raised against CREB protein gene  (lanes 4, 6) . By contrast NF-YB protein in TD cells is always expressed and, as expected, the level of expression is higher in transfected (lane 5) than in untransfected cells (lane 4). To exclude that dierent amounts of loaded protein might be responsible for the observed dierences, the same blot was checked with an anti-CREB antibody. The observation that the levels of expression of the CREB protein are similar in dierent samples indicate that the loss of NF-YA expression in TD C2C12 cells can not be attributed to technical problems. We therefore conclude that overexpression of an exogenous NF-YA protein in TD cells is prevented and that the switch-o of its expression is speci®c. Indeed we do not observe similar downregulation of exogenous NF-YB protein.
Discussion
Although it has been reported that cyclin B1 expression is down-regulated in several dierentiated cell types (Doerner et al., 1996; Fromm and Overbeek, 1996; Hanley-Hyde et al., 1992; Ohkubo et al., 1994; Zhao et al., 1995) , the molecular mechanisms underlying this modulation are still unknown. The aim of this study is to elucidate the mechanism(s) controlling the expression of the cyclin B1 gene in the TD skeletal muscle cell line C2C12. This is the ®rst report which identi®es molecular complexes involved in the down-regulation of cyclin B1 expression in terminally dierentiated cells. The data reported here suggest a model whereby the transcription of cyclin B1 is supported by NF-Y in proliferating cells and is switched o in post-mitotic cells, concomitantly with the loss of a functional NF-Y complex.
We here report that in TD C2C12 cells cyclin B1 gene expression is down-regulated at protein level. This observation is in good agreement with the ®nding that the proteolytic machinery of the mitotic-type cyclins is active in TD C2C12 cells (Brandeis and Hunt, 1996) . It has been previously reported that also cyclin B1 mRNA is down-regulated in terminally dierentiated cells (Ohkubo et al., 1994) . The ®nding that in TD cells both protein and mRNA are down-regulated indicates that cyclin B1 expression in these cells is regulated both at post-transcriptional and transcriptional level. Accordingly, we ®nd that cyclin B1 promoter activity is also down-regulated under these conditions.
The functional analysis of a truncated cyclin B1 promoter construct in stably transfected cells shows that 57 bp of the upstream sequence and 182 bp of the transcribed non-translated sequence are sucient to confer dierentiation-dependent repression of a CAT reporter gene in post-mitotic C2C12 cells. Interestingly, we previously demonstrated that this region is not sucient to confer growth arrest-dependent repression in quiescent NIH3T3 cells necessary for the transcriptional inactivation of the cyclin B1 promoter in the region from nt 7158 to 758 (Piaggio et al., 1995; Farina et al., 1996) . Thus, dierent molecular pathways act to down-regulate cyclin B1 promoter in the two dierent post-mitotic states (terminal dierentiation versus quiescence).
The promoter region sucient to confer differentiation-dependent down-regulated activity in TD cells contains two CCAAT boxes. Mutations of both CCAAT boxes lead to a dramatic decrease in the reporter gene expression in proliferating C2C12 cells. Interestingly, when each CCAAT box is individually mutated the expression of the reporter gene is not aected. These data suggest that each one of the CCAAT elements is sucient in supporting the basal transcription of the cyclin B1 promoter.
By DNA-binding competition and antibody supershift experiments, we unambiguously identi®ed NF-Y as the CCAAT-binding factor interacting with both these elements. The direct evidence that NF-Y is required for the activity of cyclin B1 promoter was obtained using a dominant negative mutant. In transient transfection experiments we demonstrate that the dominant negative mutant of NF-Y is able to completely inhibit cyclin B1 promoter activity. These results establish that NF-Y is a rate-limiting transcription factor for the overall cyclin B1 promoter activity. Since the binding activity of NF-Y to CCAAT boxes is highly ecient in proliferating cells, while it is dramatically reduced in TD cells, it is inferred that the loss of a functional NF-Y complex might be 1 and 4) , NF-YB (lanes 2 and 5), and NF-YA (lanes 3 and 6) transfected P and TD C2C12 cells respectively. The extracts were probed with two polyclonal antiserum raised against a C-terminal peptide of NF-YA (pRaYA/C) (Mantovani et al., 1992) or against the recombinant NF-YB protein (pRaYB) (Mantovani et al., 1992) respectively. To normalize protein loading, the ®lter was stained with a rabbit polyclonal antiserum raised against CREB protein responsible for the down-regulation of cyclin B1 transcription in TD cells.
To elucidate the molecular mechanism responsible for the loss of binding activity we investigated the expression of NF-Y subunits in TD C2C12 cells. Our observations indicate that NF-YA protein is completely down-regulated in terminally dierentiated cells. A decrease in the mRNA levels of NF-YA, NF-YB and NF-YC is also observed in terminally dierentiated C2C12 cells, but only NF-YA protein is undetectable in these conditions. This is the ®rst report indicating that NFY-A is down-regulated in TD cells, nevertheless a modulation of NF-YA protein has been previously reported. Reduction of NF-YA expression has been reported in IMR-90 ®broblasts after serumdeprivation (Chang and Liu, 1994) whereas an increase in NFY-A expression was observed during maturation of human peripheral monocytes to macrophages (Marziali et al., 1997) . The observations that during maturation of monocytes to macrophages NFY-A protein expression increases whereas in terminally dierentiated C2C12 cells NFY-A protein is undetectable, can be reconciled considering that in macrophages several genes require NF-Y function. MHC class II and other genes involved in antigen presentation are critically dependent upon their CCAAT sequences. By contrast, none of the muscle speci®c promoters cloned so far has been shown to depend upon NF-Y activity. In fact, among the 120 dierent promoters activated by NF-Y we found none speci®cally active in myotubes (Mantovani, 1998) . Therefore it might be speculated that the absence of NFY-A relies on a tissue-speci®c dierentiation status of the cells.
We were able to reconstitute NF-Y binding to both cyclin B1 CCAAT boxes by adding recombinant NF-YA to nuclear extracts from TD C2C12 cells, thus proving that the NF-YB/NF-YC dimers still present in TD cells cannot bind DNA in the absence of their companion subunit (NFY-A). Furthermore, evidence that the loss of CCAAT binding activity is due to the lack of NF-YA in the nuclear extracts from TD C2C12 cells is given. In TD myotubes the addition of NF-YA restores binding activity at the same level as occurs in nuclear extracts from proliferating myoblasts ( Figure  7 ). This observation suggests that the amount of NF-YA in proliferating cells determines the levels of DNA binding activity of the NF-Y complex and, at least in vitro, the amount of NF-YB/NF-YC dimers still present in myotubes is comparable to the amount that in myoblasts is involved in the binding with NF-YA.
Based on the observation that NF-YA is a limiting factor for the binding activity of NF-Y complex in vitro, we tried to restore cyclin B1 promoter activity in TD C2C12 cells by the constitutive over-expression of NF-YA protein. Surprisingly, we found that the overexpression of exogenous NF-YA is not allowed in terminal dierentiated C2C12 cells. One possible explanation is that cells transfected with NF-YA die when switched to dierentiation medium thus indicating an important role of this gene in the switch from proliferation to dierentiation. Otherwise, the fact that we were unable to express exogenous NFY-A protein in terminally dierentiated cells has to be attributed to dierent protein stability between proliferating and TD cells or to post-translational mechanisms present in TD cells. Indeed NF-YA cDNA is driven by SV40 constitutive promoter and the constructs do not contain untranslated 5' or 3' regions. Moreover, the same construct generates signi®cant expression of NFYA protein in proliferating cells ( Figure 5 ). In good agreement with this hypothesis the expression of signi®cant amounts of exogenous NF-YB protein was achieved in terminally dierentiated cells using the same vector. According to these results we speculate that similar mechanism/s are also responsible for the down-regulation of the endogenous NF-YA protein observed in Figure 6b .
Finally, the data presented indicate that the histonefold containing NF-YB/NF-YC dimers are constitutively distributed in the cells independently on their functional status. In fact their expression is largely maintained upon terminal dierentiation, albeit at reduced levels. The activity of NFY complex apparently is regulated by the NFY-A subunit. Elucidation of the regulatory circuits governing NF-YA protein levels, possibly by control of translation and/or proteolysis, will shed further light on the biology of this conserved protein.
It is interesting to notice that the promoters of several cell cycle regulatory genes such as murine cyclin B2, human cyclin A, CDK1, and CDC25C do all contain CCAAT boxes. Furthermore, NF-Y complex has been reported to bind these sequences (Zwicher et al., 1995 and RM, unpublished data) . For some of these genes, the role of NF-Y in the basal transcription has yet to be demonstrated (Zwicher et al., 1995) . This evidence, together with our ®nding that cyclin A and CDK1 promoters are down-regulated in TD C2C12 cells (data not shown) support the hypothesis that the transcription of these genes in post-mitotic skeletal muscle cells is down-regulated by the same common mechanism presently described for the cyclin B1 gene.
Materials and methods
Reporter plasmid constructs
p332B1CAT and p240B1CAT have been already described (Piaggio et al., 1995) . The reporter plasmids containing a mutation in one or both of the CCAAT box elements were generated using the QuikChange TM Site-Directed Mutagenesis Kit (Stratagene). The primers, used are the following (mutated nucleotides are underlined): 5'-GCGACC-GCAGCCGCTCGAGGGAAGGGAGTGAGTGC-3' and its complementary sequence to generate the pmtupC-CAAT reporter plasmid; 5'-GAGTGCCACGAACAG-GCTCGAAAGGAGGGAGCAGTGCGG-3' and its complementary sequence to generate the pmtdownCCAAT reporter plasmid; and both couples of the above primers to generate the pmtup/downCCAAT reporter plasmid. The mutations were con®rmed by DNA sequencing.
The plasmid CMVbgal, expressing a b-galactosidase cDNA under the control of the cytomegalovirus immediateearly promoter, has been used as an internal control in transient transfection experiments.
Cell culture, DNA transfections and CAT assay
The mouse myoblast line C2C12 (Blau et al., 1985) a clone derived from C2 cell line (Yae and Saxel, 1977) was cultured in DMEM containing 10% foetal bovine serum (FBS) and antibiotics. Dierentiation was induced by plating the cells into collagen-coated dishes and switching them to serum free (SF) medium for 48 h: DMEM supplemented with Redu-Ser (Upstate Biotechnology Incorporated, Lake Placid, NY, USA) to a ®nal concentration of 5 mg/ml human insulin, 5 mg/ml human (holo) transferrin, and 5 ng/ml sodium selenite. Fifty mM Ara-C was added to the SF medium to eliminate undierentiated cells. As previously described (Tiainen et al., 1996) , more than 90% of the cells become terminally dierentiated under these conditions. Transient DNA transfections were performed using the calcium phosphate precipitation technique (Graham and Van Der Eb, 1973) modi®ed by Okayama (Chen and Okayama, 1987) . In each 60-mm plate, 1.5610 5 cells were transfected with precipitates containing: 10 mg of p240B1CAT, pmtupC-CAAT, pmtdownCCAAT plasmid or pmtup/downCCAAT; 1 mg of CMVbgal plasmid as an internal control for transfection eciency. For cotransfection experiments the precipitates contained: (i) 5 mg of p240B1CAT, or SV2CAT; (ii) 0.5 mg of CMVbgal plasmid as an internal control for transfection eciency; and only in cotransfection experiments, (iii) 2.5 mg or 5 mg of an eucariotic expression vector for NF-YA dominant negative (Mantovani et al., 1994) . Sixteen hours later, the precipitate was removed, and fresh medium was added. Cells were harvested from 24 ± 48 h after transfection and CAT activity was assayed in whole-cell extracts as described (Desvernie et al., 1991) .
Stably transfected C2C12 cells were generated using the calcium phosphate precipitation technique (Graham and Van Der Eb, 1973) modi®ed by Okayama (Chen and Okayama, 1987) . Cells were cotransfected with p332B1CAT or p240B1CAT reporter plasmids and a vector containing the hygromycin resistance gene under the control of the SV40 promoter (pBabeHygro). The culture medium was replaced 12 h after seeding, and the cells were exposed to the selection medium after an additional 48 h (DMEM plus hygromycin 300 mg/ml).
Northern blot analysis
C2C12 cells were plated at 5610 6 cells/collagen-coated, 150-mm dish and induced to dierentiate in the presence of Ara-C. Total cellular RNA was extracted by the guanidinium thiocyanate/phenol procedure (Chomczynski and Sacchi, 1987 ) from myotubes as well as from proliferating C2C12 cells. Samples were loaded (25 mg/ lane) on formaldehyde gels, then separated and blotted. Filters were hybridized with murine NF-YA, human NF-YB, NF-YC, cyclin B1, and GAPDH cDNA probes according to standard protocols (Sambrook et al., 1989) . The probes were labelled using a-32 P-dATP and the random priming procedure according to the manufacturer's speci®cations (Boehringer, Mannheim, Germany).
Total-cell lysate and Western blot analysis
Total-cell lysate was obtained from proliferating and TD C2C12 cells by freeze-thaw in 0.4 M NaCl buer containing 50 mM Tris-HCl (pH 8), 25% glycerol 1 mM EDTA, 2.5 mM DTT, 10 mg/ml leupeptin, 4 mg/ml pepstatin, 5 mg/ml aprotinin, 50 mM NaF, 1 mM orthovanadate and 1 mM PMSF. To compensate for the higher structural protein content in myotubes compared to myoblasts, 50 and 100 mg of proteins obtained from proliferating and TD cells respectively were loaded and separated by SDS ± PAGE (12% polyacrylamide) and electro-blotted onto nitrocellulose. After staining in 0.2% Ponceau S in 3% TCA, the ®lter was washed twice in PBS and protein binding sites blocked in 5% non-fat dried milk in PBS. The ®lter was washed twice in PBS and treated with 0.3 mg/ml of polyclonal antiserum pRaYA/C, or pRaYB (Marziali et al., 1997) , or 33 ng/ml of anti cyclin B1 mouse monoclonal antibody (Santa Cruz Biotechnology, Inc. CA, USA), or 50 ng/ml of anti CREB rabbit polyclonal antibody (New England Biolabs), in 3% BSA /PBS for 2 h at room temperature. After four washes in TBS (150 mM NaCl, 50 mM Tris-HCl, pH 7.9) the ®lter was incubated with the secondary antibody (anti-rabbit or anti-mouse Ig conjugated with peroxidase), in 3% BSA/TBS for 1 h at room temperature. The ®lter was washed four times as above and blots were developed using the ECL procedure (Amersham, Little Chalfont, UK).
Electromobility shift assays and nuclear extracts
Electromobility shift assays were performed in a 25 ml DNA binding reaction which contained 5 ± 10 mg of C2C12 nuclear extracts, 4 fmol of labelled duplex oligonucleotide, binding buer (20 mM Tris-HCl pH 7.8, 60 mM KCl, 0.5 mM EDTA, 0.1 mM DTT, 3 mM MgCl 2 ), 1.5 mg of poly (dl-dC), and 10 mM spermidine. The reaction was carried out on ice for 30 min and the protein-DNA complexes were subjected to native electrophoresis on 5% polyacrylamide, 0.56TBE gels. The following oligonucleotides were used as probes and competitors (consensus sites are underlined): B1upCCAAT: 5'-CCGCAGCCG CCAATGGGAAGGGAGTGA; B1downCCAAT: 5'-GT-G AG TGCC AC G AAC AGGCCAATAAG GAG GG AG; B1upCTCGA: 5'-GCGACCGCAGCCGCTCGAGGGAA-GGGAGTGAGTGC; B1downCTCGA: 5'-GAGTGCC-ACGAA CAG GCTCGAAAGGAG GGAGCA GTGCGG; CRE: 5'-CTTGGCTGACGTCAGAGAGA. In supershift experiments the following antibodies were added to the mixture before the labelled oligonucleotide and incubated for 10 ± 20 min: anti-NF-YA mouse monoclonal antibody mAbYA7 or anti-NF-YB rabbit polyclonal antibody pRaYB (Mantovani et al., 1993) . Nuclear proteins were extracted from proliferating or TD C2C12 cells as described (Digna et al., 1983) with the following modi®cations: cell pellets were resuspended in a buer containing 10 mM HEPES (pH 7.9), 1.5 mM MgCl 2 , 10 mM KCl and 0.5 mM DTT, leupeptin 10 mg/ml, pepstatin 4 mg/ ml, aprotinin 5 mg/ml, 50 mM NaF, 1 mM orthovanadate and 1 mM PMSF. Cells were broken in a Dounce homogenizer, nuclei separated by centrifugation, and cytoplasmic extracts were stored in aliquots at 7808C. Proteins from nuclei were extracted in the following buer: 20 mM HEPES (pH 7.9), 25% glycerol, 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT. The production of NF-YA, NF-YB, and NF-YC recombinant protein has been described (Mantovani et al., 1992) .
